𝔖 Bobbio Scriptorium

✦ LIBER ✦

Th-P16:281 Evaluation of the ezetimibe/simvastatin tablet compared with atorvastatin or rosuvastatin on C-reactive protein in patients with hypercholesterolemia

✍ Scribed by Calapano, A.L.; Ballantyne, C.M.; Abate, N.; Davidson, M.H.; Brady, W.E.; Gazzara, R.A.; Tershakovec, A.

Book ID: 115537651
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 143 KB
Volume: 7
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(06)82239-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ezetimibe/simvastatin compared with ator

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein

✍ Michael H. Davidson; Nicola Abate; Christie M. Ballantyne; Alberico L. Catapano; 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 263 KB

Achievement of specified low-density lip

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 469 KB